Navigation Links
Americans Living Longer, Healthier Lives Due to Medical Innovation and New Therapies
Date:2/23/2010

WASHINGTON, Feb. 23 /PRNewswire-USNewswire/ -- An article in the Journal Miner recently highlighted the fact that many people are living longer, healthier and more productive lives thanks to medical innovation and research.

"A strong, innovative and creative pharmaceutical research and biotechnology sector based in the United States is a real boon to American patients," said Billy Tauzin, president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA).

For example, according to a study in Health Affairs, cancer patients live three years longer on average than thirty years ago; 83 percent of that gain is the result of new treatments. In addition, there was a nearly 50 percent decline in heart failure- and attack-related deaths between 1999 and 2005. The rate of AIDS deaths has fallen by more than 70 percent since highly active anti-retroviral therapies were developed, blood pressure medicines prevented 86,000 premature deaths from cardiovascular disease and avoided 833,000 hospitalizations for heart attack and stroke in just one year.

America's pharmaceutical research and biotechnology companies are leading the charge. "American patients often get access to new and better medicines well ahead of patients around the world, and this homegrown innovation not only saves lives, it helps the American economy by employing millions of Americans and pumping billions of dollars into our local and national economies," Tauzin said.

The Congressional Budget Office specifically identified America's biopharmaceutical sector as "one of the most research-intensive industries" in America. Tauzin said, "It's important to keep in mind that developing new therapies can be risky, expensive and time consuming. Creating a new medicine, on average, takes between 10 and 15 years and can cost $1.3 billion. But it's an investment biopharmaceutical research companies make because nothing is as important as the search for new cures and treatments that help patients live longer, healthier lives."

SOURCE Pharmaceutical Research and Manufacturers of America

Back to top

RELATED LINKS
http://www.phrma.org/

'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Aspirin Named 8th World Wonder by Majority of Americans
2. Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination
3. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
5. Lack of Medicare Part D Coverage for All Medically Necessary Prescriptions Endangers Older Americans and Those with Chronic Diseases and Disabilities
6. New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline
7. More Than 1.5 Million Americans Sickened, Injured or Killed by Medication Errors Each Year; Seniors Most at Risk
8. Family of Three Americans Become Pain Free and Improve Their Quality of Life With Stem Cell Treatment in Mexico
9. World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research
10. Alzheimers Foundation of America Survey: Americans With Memory Concerns Fall Short of Talking to Doctors
11. New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):